MI
The startup develops multifunctional biopharmaceuticals targeting rare diseases, utilizing a streamlined drug development process for new biologics. This approach significantly reduces the time required for drug discovery, providing cost-effective alternatives to existing treatments.
Updated 3 months ago
Funding
$9.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops multifunctional biopharmaceuticals targeting rare diseases, utilizing a streamlined drug development process for new biologics. This approach significantly reduces the time required for drug discovery, providing cost-effective alternatives to existing treatments.